The American Academy of Periodontology issues statement on periodontal treatment during pregnancy
(31 January 2009: VIDYYA MEDICAL NEWS SERVICE) -- A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.
While the American Academy of Periodontology (AAP) has not yet received the opportunity to review the complete study findings, it continues to urge women to care for their periodontal health while pregnant, through regular tooth brushing and flossing, and routine visits to a dental professional, such as a periodontist, to screen for periodontal disease.
These study results demonstrate the need for additional research to clarify the potential impact that periodontal disease has on the risk of preterm births; and if needed, what periodontal treatment modalities are most effective in helping to prevent premature deliveries.
As the organization representing over 8,000 dentists specially trained in the diagnosis, treatment and prevention of periodontal disease, the AAP is eager to analyze the complete study results, and provide women with accurate and effective recommendations on the management of periodontal disease during pregnancy.
Return to Vidyya Medical News Service for 31 January 2009
© Vidyya. All rights reserved.
Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.
Interested in subscribing to our daily e-mail newsletter? Send an email to Vidyya@vidyya.com with the word subscribe in the subject field.